fluoxetine has been researched along with resveratrol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Dutour, R; Poirier, D | 1 |
| Chen, C; Du, X; Li, J; O'Donnell, JM; Pan, J; Ruan, L; Sun, J; Wang, R; Xu, Y; Yu, Y; Zhang, L | 1 |
| Abbas, AM; Elsamanoudy, AZ; Ghoneim, FM; Sakr, HF | 1 |
| Chen, JJ; Fang, XY; Li, YC; Liu, YM; Pei, YY; Shen, JD | 1 |
| Qu, C; Shen, J; Sun, H; Xu, L; Zhang, J | 1 |
| Anoopkumar-Dukie, S; Arora, D; Davey, AK; Govindula, A; Grant, GD; Kinra, M; Mudgal, J; Nampoothiri, M; Ranadive, N; Zhang, Y | 1 |
2 review(s) available for fluoxetine and resveratrol
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
Inhibitors of cytochrome P450 (CYP) 1B1.
Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship | 2017 |
5 other study(ies) available for fluoxetine and resveratrol
| Article | Year |
|---|---|
Antidepressant-like effect of trans-resveratrol in chronic stress model: behavioral and neurochemical evidences.
Topics: Adrenal Glands; Animals; Antidepressive Agents; Body Weight; Brain; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Escape Reaction; Fluoxetine; Food Preferences; Gene Expression Regulation; Imipramine; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Stress, Psychological; Sucrose; Sweetening Agents; Time Factors; Water Deprivation | 2013 |
Effect of fluoxetine and resveratrol on testicular functions and oxidative stress in a rat model of chronic mild stress-induced depression.
Topics: Animals; Antidepressive Agents, Second-Generation; Antioxidants; Body Weight; Depression; Fluoxetine; Gene Expression Regulation; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Sperm Count; Sperm Motility; Stilbenes; Stress, Psychological; Swimming; Testis | 2015 |
Resveratrol Ameliorates the Depressive-Like Behaviors and Metabolic Abnormalities Induced by Chronic Corticosterone Injection.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Blood Glucose; Body Weight; Corticosterone; Depression; Disease Models, Animal; Drug Administration Schedule; Fluoxetine; Lipids; Male; Mice; Mice, Inbred ICR; Pioglitazone; Resveratrol; Stilbenes; Swimming; Thiazolidinediones | 2016 |
Resveratrol exerts a protective effect in chronic unpredictable mild stress-induced depressive-like behavior: involvement of the AKT/GSK3β signaling pathway in hippocampus.
Topics: Animals; Antidepressive Agents; Antioxidants; Behavior, Animal; Cytokines; Depression; Fluoxetine; Glycogen Synthase Kinase 3 beta; Hippocampus; Interleukin-1beta; Interleukin-6; Male; Prefrontal Cortex; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stress, Psychological; Tumor Necrosis Factor-alpha | 2019 |
Putative involvement of sirtuin modulators in LPS-induced sickness behaviour in mice.
Topics: Animals; Antioxidants; Enzyme Inhibitors; Fluoxetine; Illness Behavior; Lipopolysaccharides; Male; Mice; Oxidative Stress; Resveratrol; Sirtuins; Tumor Necrosis Factor-alpha | 2022 |